0001437749-21-025299 8-K 15 20211104 2.02 9.01 20211104 20211104 SAFEGUARD SCIENTIFICS INC 0000086115 6799 231609753 PA 1231 8-K 34 001-05620 211380477 150 NORTH RADNOR-CHESTER ROAD SUITE F-200 RADNOR PA 19087 610 293 0600 150 NORTH RADNOR-CHESTER ROAD SUITE F-200 RADNOR PA 19087 SAFEGUARD INDUSTRIES INC 19810525 SAFEGUARD CORP 19690521 8-K 1 sfe20211104_8k.htm FORM 8-K sfe20211104_8k.htm
false 0000086115 0000086115 2021-11-04 2021-11-04
 


 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 4, 2021
 
Safeguard Scientifics, Inc.
(Exact Name of registrant as Specified in Charter)
 
 
Pennsylvania
1-5620
23-1609753
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer ID No.)
 
150 N. Radnor Chester Rd., STE F-200
Radnor, PA
19087
(Address of Principal Executive Offices)
(Zip Code)
 
Registrant’s telephone number, including area code: 610-293-0600
 
Not applicable 

(Former Name or Former Address if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock ($.10 par value)
SFE
New York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 
 

 
 
Item 2.02.
Results of Operations and Financial Condition.
 
On November 4, 2021, Safeguard Scientifics, Inc. (the “Company”) issued a press release setting forth the Company’s financial information for the three and nine months ended September 30, 2021. A copy of the Company’s press release is attached hereto as Exhibit 99.1 and is hereby incorporated by reference.
 
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (“Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
ITEM 9.01.
Financial Statements and Exhibits.
 
(d)
Exhibits.
 
99.1
104
Cover Page Interactive Data File (formatted as Inline XBRL).
 
2

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Safeguard Scientifics, Inc.
 
       
       
Date: November 4, 2021
By:
/s/ G. Matthew Barnard
 
 
Name: G. Matthew Barnard
 
 
Title:   General Counsel
 
 
3
EX-99.1 2 ex_302651.htm EXHIBIT 99.1 ex_302651.htm

Exhibit 99.1

 

logo.jpg 

 

SAFEGUARD SCIENTIFICS ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS

 

Successful Completion of $39mm Self-tender Offer

 

 

Conference call and webcast on November 4, 2021 at 5 p.m. ET

 

 

Radnor, PA, November 4, 2021Safeguard Scientifics, Inc. (NYSE:SFE) (“Safeguard” or the “Company”) today announced financial results for the three and nine months ended September 30, 2021.

 

HIGHLIGHTS

 

 

Capital Return

 

o

On October 7, 2021, Safeguard completed a modified Dutch auction self-tender that resulted in the repurchase of 4.3 million shares of its common stock at a cost of $9.00 per share or a total of $38.7 million.

 

 

Exits & Deployments

 

o

Flashtalking was acquired by Mediaocean resulting in $44.8 million of cash proceeds upon the closing. As a result of this exit, Safeguard reported a gain of $32.3 million.

 

o

Safeguard funded $1.7 million to Aktana as part of a larger financing.

 

 

Safeguard Company Performance

 

o

During the third quarter, Safeguard’s 1.3 million shares of Bright Health common stock experienced an unrealized decline in their fair value of $11.9 million. Based on the closing price as of September 30, 2021, the fair value of Safeguard’s Bright Health common stock was $10.8 million.

 

o

Trice Medical raised growth equity capital from a strategic investor, Bioventus, and all outstanding stockholder convertible loans and interest were converted into equity. As a result of this transaction, Safeguard’s primary ownership interest in Trice was reduced to 12.6% and a $2.0 million dilution gain was recorded.

 

o

The aggregate trailing twelve-month revenues ending June 30, 2021 for Safeguard’s ten companies, which excludes Flashtalking, Bright Health and Other Ownership Interests, was $245 million, down 11% from the comparable prior period.

 

 

Financial Results

 

o

Cash, cash equivalents and restricted cash totaled $64.2 million at September 30, 2021.

 

o

The carrying value of the Company’s ownership interests totaled $36.3 million at September 30, 2021, which includes the Bright Health common stock noted above. The total cost of the ownership interests was $155.8 million.

 

o

Net income for the three months ended September 30, 2021 was $18.3 million, or $0.88 per share, as compared with a net loss of $4.3 million, or $0.21 per share, for the same period in 2020.

 

 

Operating Costs

 

o

Safeguard continued to reduce its operating costs in 2021. General and administrative expenses totaled $1.6 million for the third quarter of 2021 as compared to $2.3 million for the comparable period of 2020.

 

o

Safeguard also continued to lower its corporate expenses, which totaled $0.9 million for the third quarter of 2021, as compared to $1.3 million for the comparable period of 2020, a 32% decline.

 

 

Outlook

 

o

Year to date, Safeguard has deployed $2.7 million to our companies. We do not expect material deployments for the remainder of 2021.

 

“The completion of our self-tender was a milestone event for Safeguard and represented a substantial return of capital to our shareholders,” said Eric C. Salzman, Chief Executive Officer. “We remain optimistic about our remaining portfolio of companies and continue to work with our management teams to create value and drive additional monetization opportunities.”

 


1 Corporate expenses are general and administrative expenses excluding depreciation, severance, stock-based compensation and other non-recurring items.  See full reconciliation in the financial section of this statement.

 

www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. 1 of 6

 

 

logo.jpg

 

OWNERSHIP INTERESTS AT SEPTEMBER 30, 2021

Companies

Category

Acquisition

Year

 

Primary

Ownership%

   

Fully Diluted

Ownership%**

   

Carrying

Value

(in millions)

   

Cost

(in millions)

 
                                     
 

Initial Revenue Stage: Up to $1 million

 

None

                                   
 

Revenue of $1 million to $5 million

 

Moxe Health Corporation

Healthcare

2016

    27.6 %     25.8 %   $ 4.3     $ 7.5  
 

Revenue of $5 million to $10 million

 

Lumesis, Inc.

Financial Services

2012

    43.2 %     43.4 %     1.4       5.6  
 

Revenue of $10 million to $20 million

 

Clutch Holdings, Inc.+

Digital Media

2013

    41.7 %     33.0 %     4.4       16.9  

InfoBionic, Inc.

Healthcare

2014

    25.2 %     22.1 %     -       22.0  

meQuilibrium

Healthcare

2015

    31.9 %     23.1 %     2.5       14.0  

Syapse, Inc.++

Healthcare

2014

    11.1 %     8.9 %     5.6       25.0  

Trice Medical, Inc.+

Healthcare

2014

    12.6 %     10.7 %     2.5       11.8  
 

Revenue of $20 million to $50 million

 

Aktana, Inc.

Healthcare

2016

    15.0 %     11.6 %     0.8       15.9  

Prognos Health, Inc.

Healthcare

2011

    28.5 %     24.5 %     3.1       12.6  
 

Greater than $50 million in revenue

 

MediaMath, Inc.

Digital Media

2009

    13.2 %     10.1 %     -       15.5  
 

Other Ownership Interests

 

Bright Health Group

Healthcare

2021

                    10.8       -  

All others

Various

                    0.9       9.0  
               

TOTAL:

    $ 36.3     $ 155.8  

 

 

+ Company progressed into higher revenue stage this quarter.

++ Company dropped into a lower revenue stage this quarter.

** Based on information provided by each respective company. Assumes the conversion or exercise of all currently outstanding securities including the issuance of all shares available under authorized employee equity programs. Does not reflect liquidation preferences, priority payments, proceeds from option and/or warrant exercises or other company-specific transaction-related obligations in a liquidation or exit transaction.

 

www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. 2 of 6

 

logo.jpg

 

CONFERENCE CALL AND WEBCAST DETAILS

 

Please call 10-15 minutes prior to the call to register.

 

Date: November 4, 2021

 

Time: 5 p.m. ET

 

Webcast: https://events.q4inc.com/attendee/688077299

 

Live Number: 844-200-6205

 

Access Code: 552674

 

Speakers: Chief Executive Officer, Eric C. Salzman; and Senior Vice President and Chief Financial Officer, Mark A. Herndon

 

Format: Discussion of the quarter’s financial results followed by Q&A

 

The replay will be available by telephone (866-813-9403; access code 457186) through November 11, 2021. The webcast replay will be available for 90 days at Safeguard.com’s investor relations site under “Past events”. For more information please contact IR@safeguard.com. 

 

About Safeguard Scientifics

Historically, Safeguard Scientifics has provided capital and relevant expertise to fuel the growth of technology-driven businesses. Safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades. Safeguard is currently pursuing a focused strategy to value-maximize and monetize its ownership interests over a multi-year time frame to drive shareholder value. For more information, please visit www.safeguard.com.

 

Forward-Looking Statements

Except for the historical information and discussions contained herein, statements contained in this release may constitute forward-looking statements. Our forward-looking statements are subject to risks and uncertainties. Forward-looking statements include, but are not limited to, statements regarding Safeguards ability to maximize the value of monetization opportunities of its ownership interests and drive total shareholder returns. Safeguards initiatives taken or contemplated to enhance and unlock value for all of its shareholders, Safeguards efforts to execute on and implement its strategy to streamline its organizational structure, reduce its operating costs, pursue monetization opportunities for ownership interests and maximize the return of value to its shareholders, Safeguards ability to create, unlock, enhance and maximize shareholder value, the effect of Safeguards management succession plan on driving increased organizational effectiveness and efficiencies, the ability of the management team to execute Safeguards strategy, the availability of, the timing of, and the proceeds that may ultimately be derived from the monetization of ownership interests, Safeguards projections regarding the reduction in its ongoing operating expenses, Safeguards projections regarding annualized operating expenses and expected severance expenses, monetization opportunities for ownership interests, and the amount of net proceeds from the monetization of ownership interests that will enable the return of value to Safeguard shareholders after satisfying working capital needs and the timing of such return of value. Such forward-looking statements are not guarantees of future operational or financial performance and are based on current expectations that involve a number of uncertainties, risks and assumptions that are difficult to predict. Therefore, actual outcomes and/or results may differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the monetization of our ownership interests for maximum value or at all and the return of value to our shareholders, our ability to successfully execute on our strategy to streamline our organizational structure and align our cost structure to increase shareholder value, whether our strategy will better position us to focus our resources on the highest-return opportunities and deliver enhanced shareholder value, the ongoing support of our existing ownership interests, the fact that our companies may vary from period to period, challenges to achieving liquidity from our ownership interests, fluctuations in the market prices of our publicly traded holdings, if any, competition, our inability to obtain maximum value for our ownership interests, our ability to attract and retain qualified employees, market valuations in sectors in which our ownership interests operate, our inability to control our ownership interests, our need to manage our assets to avoid registration under the Investment Company Act of 1940, risks, disruption, costs and uncertainty caused by or related to the actions of activist shareholders, including that if individuals are elected to our Board with a specific agenda, it may adversely affect our ability to effectively implement our business strategy and create value for our shareholders and perceived uncertainties as to our future direction as a result of potential changes to the composition of our Board may lead to the perception of a change in the direction of our business, instability or a lack of continuity that may adversely affect our business, and risks associated with our ownership interests, including the fact that most of our ownership interests have a limited operating history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which our companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond our ability to predict or control. As a result of these and other factors, the Companys past operational and financial performance should not be relied on as an indication of future performance. Further information on the above risk factors and other potential factors that could affect our future business, operating results and financial condition is included in our Annual Report on Form 10-K for the year ended December 31, 2020 and other periodic filings with the Securities and Exchange Commission, including risks under the heading Risk Factors. The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.

 

###

 

SAFEGUARD CONTACT:

Mark Herndon

Chief Financial Officer

(610) 975-4913

mherndon@safeguard.com

 

www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. 3 of 6

 

 

logo.jpg

 

Safeguard Scientifics, Inc.

Condensed Consolidated Balance Sheets

(in thousands)

 

   

September 30,

2021

   

December 31,

2020

 

Assets

               

Cash, cash equivalents and restricted cash

  $ 64,236     $ 15,601  

Ownership interests

    10,792        

Other current assets

    1,343       462  

Total current assets

    76,371       16,063  

Ownership interests in and advances

    25,492       50,398  

Other assets

    1,855       2,574  

Total Assets

  $ 103,718     $ 69,035  
                 

Liabilities and Equity

               

Other current liabilities

  $ 3,899     $ 3,470  

Total current liabilities

    3,899       3,470  

Lease liability - non-current

    1,776       2,053  

Other long-term liabilities

    50       637  

Total equity

    97,993       62,875  

Total Liabilities and Equity

  $ 103,718     $ 69,035  

 

www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. 4 of 6

 

logo.jpg

 

Safeguard Scientifics, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2021

   

2020

   

2021

   

2020

 

Operating expenses

  $ 1,564     $ 2,275     $ 6,018     $ 7,835  

Operating loss

    (1,564

)

    (2,275

)

    (6,018

)

    (7,835

)

Other income (loss), net

    20,588       (820

)

    28,027       (7,045

)

Interest, net

    70       52       197       209  

Equity income (loss), net

    (761

)

    (1,300

)

    13,432       (15,591

)

Net income (loss) before income taxes

    18,333       (4,343

)

    35,638       (30,262

)

Income tax benefit (expense)

                       

Net income (loss)

  $ 18,333     $ (4,343

)

  $ 35,638     $ (30,262

)

Net income (loss) per share:

                               

Basic

  $ 0.88     $ (0.21

)

  $ 1.71     $ (1.46

)

Diluted

  $ 0.88     $ (0.21

)

  $ 1.71     $ (1.46

)

Weighted average shares used in computing income (loss) per share:

                               

Basic

    20,786       20,786       20,847       20,731  

Diluted

    20,786       20,786       20,847       20,731  

 

www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. 5 of 6

 

logo.jpg

 

Safeguard Scientifics, Inc.

Financial Data

(in thousands)

 

Additional Financial Information

 

Non-GAAP Measures

 

In discussing financial results and guidance, the Company refers to the measure "corporate expenses" which is not in accordance with Generally Accepted Accounting Principles (GAAP). We use this non-GAAP financial measure internally to make operating and strategic decisions, including evaluating our overall performance and as a factor in determining compensation for certain employees. We have defined corporate expenses as general and administrative costs excluding stock based compensation, severance costs, and non-recurring items and other.  Non-recurring items and other includes accruals related to the Company's LTIP plan that will not be paid until reaching a specified threshold within that plan. We believe presenting this non-GAAP financial measure provides additional information to facilitate comparison of our historical operating costs and their trends, and provides additional transparency on how we evaluate our cost structure. We also believe presenting this measure allows investors to view our performance using the same measure that we use in evaluating our performance and trends.

 

Corporate expenses reconciliation:

 

 

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2021

   

2020

   

2021

   

2020

 

Corporate expenses

  $ 885     $ 1,302     $ 3,040     $ 3,997  

Stock based compensation

    484       452       1,469       979  

Severance costs

          108       774       1,873  

Non-recurring items and other

    195       413       735       986  

General and administrative expenses

  $ 1,564     $ 2,275     $ 6,018     $ 7,835  

 

www.safeguard.com © 2021 Safeguard Scientifics, Inc. All rights reserved. 6 of 6
 
EX-101.SCH 3 sfe-20211104.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 sfe-20211104_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 sfe-20211104_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 sfe-20211104_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 logo.jpg begin 644 logo.jpg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end XML 8 sfe20211104_8k_htm.xml IDEA: XBRL DOCUMENT 0000086115 2021-11-04 2021-11-04 false 0000086115 8-K 2021-11-04 Safeguard Scientifics, Inc. PA 1-5620 23-1609753 150 N. Radnor Chester Rd., STE F-200 Radnor PA 19087 610 293-0600 false false false false Common Stock SFE NYSE false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document And Entity Information
Nov. 04, 2021
Document Information [Line Items]  
Entity, Registrant Name Safeguard Scientifics, Inc.
Document, Type 8-K
Document, Period End Date Nov. 04, 2021
Entity, Incorporation, State or Country Code PA
Entity, File Number 1-5620
Entity, Tax Identification Number 23-1609753
Entity, Address, Address Line One 150 N. Radnor Chester Rd., STE F-200
Entity, Address, City or Town Radnor
Entity, Address, State or Province PA
Entity, Address, Postal Zip Code 19087
City Area Code 610
Local Phone Number 293-0600
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol SFE
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000086115
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>] M9!:G7&BN"^)]NK+NY *W3"W\RQ+50/>I"MJ(-.)_#1EZA$V MY8<1(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA+@W#"CTN*+N@U6/@24DM0H#E>QV M3N7TR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0!)?DJG547>EYIM[IFBG#S^0W1UW6E\./VR./ / M,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G M>1,)KM\,<'AT_@%02P,$% @ Z8-D4V60>9(9 0 SP, !, M !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 ! M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T.EY&TWP39G M8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9# ML9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/ MN]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DW MY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4 " #I M@V13!T%-8H$ "Q $ @ $ 9&]C4')O<',O87!P M+GAM;%!+ 0(4 Q0 ( .F#9%,MD >P[0 "L" 1 " M :\ !D;V-0&UL4$L! M A0#% @ Z8-D4X:JW_HM! 6A !@ ("!# @ 'AL M+W=O7!E&UL4$L%!@ ) D /@( - 3 $! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.sfe.com/20211104/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports sfe20211104_8k.htm ex_302651.htm sfe-20211104.xsd sfe-20211104_def.xml sfe-20211104_lab.xml sfe-20211104_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sfe20211104_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "sfe-20211104_def.xml" ] }, "inline": { "local": [ "sfe20211104_8k.htm" ] }, "labelLink": { "local": [ "sfe-20211104_lab.xml" ] }, "presentationLink": { "local": [ "sfe-20211104_pre.xml" ] }, "schema": { "local": [ "sfe-20211104.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sfe", "nsuri": "http://www.sfe.com/20211104", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "sfe20211104_8k.htm", "contextRef": "d20218K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.sfe.com/20211104/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "sfe20211104_8k.htm", "contextRef": "d20218K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.sfe.com/20211104/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001437749-21-025299-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-21-025299-xbrl.zip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end